{
  "trial_data": {
    "cancer": [
      {
        "nct_id": "NCT123456",
        "title": "Phase II Study of EGFR Inhibitor in Lung Cancer",
        "inclusion_criteria": [
          "Age 18-75 years",
          "ECOG performance status 0-1",
          "EGFR mutation positive",
          "Stage IIIB or IV non-small cell lung cancer"
        ],
        "exclusion_criteria": [
          "Prior EGFR inhibitor therapy",
          "Active brain metastases",
          "Severe cardiac disease"
        ]
      },
      {
        "nct_id": "NCT789012",
        "title": "ALK Inhibitor Trial for Advanced NSCLC",
        "inclusion_criteria": [
          "ALK rearrangement positive",
          "ECOG performance status 0-2",
          "Age 18-80 years",
          "Measurable disease"
        ],
        "exclusion_criteria": [
          "Prior ALK inhibitor treatment",
          "Uncontrolled diabetes",
          "Pregnancy"
        ]
      }
    ],
    "neurology": [
      {
        "nct_id": "NCT345678",
        "title": "Alzheimer's Disease Biomarker Study",
        "inclusion_criteria": [
          "Age 50-85 years",
          "MMSE score 20-26",
          "Amyloid PET positive",
          "No significant cognitive impairment"
        ],
        "exclusion_criteria": [
          "Other neurological disorders",
          "Severe depression",
          "Recent stroke"
        ]
      }
    ]
  },
  "terminology_results": {
    "cancer": {
      "terminologies": [
        "18-75",
        "years",
        "ECOG",
        "performance",
        "status",
        "EGFR",
        "mutation",
        "positive",
        "Stage",
        "IIIB",
        "non-small",
        "cell",
        "lung",
        "cancer",
        "rearrangement",
        "positive",
        "ECOG",
        "performance",
        "status",
        "18-80",
        "years",
        "Measurable",
        "disease"
      ],
      "frequency_analysis": {
        "term_frequencies": {
          "18-75": 1,
          "years": 2,
          "ECOG": 2,
          "performance": 2,
          "status": 2,
          "EGFR": 1,
          "mutation": 1,
          "positive": 2,
          "Stage": 1,
          "IIIB": 1,
          "non-small": 1,
          "cell": 1,
          "lung": 1,
          "cancer": 1,
          "rearrangement": 1,
          "18-80": 1,
          "Measurable": 1,
          "disease": 1
        },
        "top_terms": [
          "years",
          "ECOG",
          "performance",
          "status",
          "positive",
          "18-75",
          "EGFR",
          "mutation",
          "Stage",
          "IIIB"
        ]
      },
      "categorized_terms": {
        "demographics": [
          "Age",
          "years"
        ],
        "clinical": [
          "ECOG",
          "performance",
          "status"
        ],
        "biomarkers": [
          "EGFR",
          "ALK",
          "mutation",
          "positive"
        ],
        "pathology": [
          "cancer",
          "disease",
          "metastases"
        ]
      }
    },
    "neurology": {
      "terminologies": [
        "50-85",
        "years",
        "MMSE",
        "score",
        "20-26",
        "Amyloid",
        "positive",
        "significant",
        "cognitive",
        "impairment"
      ],
      "frequency_analysis": {
        "term_frequencies": {
          "50-85": 1,
          "years": 1,
          "MMSE": 1,
          "score": 1,
          "20-26": 1,
          "Amyloid": 1,
          "positive": 1,
          "significant": 1,
          "cognitive": 1,
          "impairment": 1
        },
        "top_terms": [
          "50-85",
          "years",
          "MMSE",
          "score",
          "20-26",
          "Amyloid",
          "positive",
          "significant",
          "cognitive",
          "impairment"
        ]
      },
      "categorized_terms": {
        "demographics": [
          "Age",
          "years"
        ],
        "clinical": [
          "ECOG",
          "performance",
          "status"
        ],
        "biomarkers": [
          "EGFR",
          "ALK",
          "mutation",
          "positive"
        ],
        "pathology": [
          "cancer",
          "disease",
          "metastases"
        ]
      }
    }
  },
  "emr_mappings": {
    "cancer": {
      "years": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_YEARS",
            "display": "years"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "years was observed in the specimen",
            "Patient shows years characteristics",
            "years levels are within normal range"
          ]
        },
        "frequency": 2
      },
      "ECOG": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_ECOG",
            "display": "ECOG"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "ECOG was observed in the specimen",
            "Patient shows ECOG characteristics",
            "ECOG levels are within normal range"
          ]
        },
        "frequency": 2
      },
      "performance": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_PERFORMANCE",
            "display": "performance"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "performance was observed in the specimen",
            "Patient shows performance characteristics",
            "performance levels are within normal range"
          ]
        },
        "frequency": 2
      },
      "status": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_STATUS",
            "display": "status"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "status was observed in the specimen",
            "Patient shows status characteristics",
            "status levels are within normal range"
          ]
        },
        "frequency": 2
      },
      "positive": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_POSITIVE",
            "display": "positive"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "positive was observed in the specimen",
            "Patient shows positive characteristics",
            "positive levels are within normal range"
          ]
        },
        "frequency": 2
      }
    },
    "neurology": {
      "50-85": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_50-85",
            "display": "50-85"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "50-85 was observed in the specimen",
            "Patient shows 50-85 characteristics",
            "50-85 levels are within normal range"
          ]
        },
        "frequency": 1
      },
      "years": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_YEARS",
            "display": "years"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "years was observed in the specimen",
            "Patient shows years characteristics",
            "years levels are within normal range"
          ]
        },
        "frequency": 1
      },
      "MMSE": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_MMSE",
            "display": "MMSE"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "MMSE was observed in the specimen",
            "Patient shows MMSE characteristics",
            "MMSE levels are within normal range"
          ]
        },
        "frequency": 1
      },
      "score": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_SCORE",
            "display": "score"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "score was observed in the specimen",
            "Patient shows score characteristics",
            "score levels are within normal range"
          ]
        },
        "frequency": 1
      },
      "20-26": {
        "fhir_mapping": {
          "resource_type": "Observation",
          "code": {
            "system": "http://loinc.org",
            "code": "LOINC_20-26",
            "display": "20-26"
          },
          "value": "string"
        },
        "report_mapping": {
          "report_types": [
            "pathology",
            "lab",
            "radiology"
          ],
          "example_mentions": [
            "20-26 was observed in the specimen",
            "Patient shows 20-26 characteristics",
            "20-26 levels are within normal range"
          ]
        },
        "frequency": 1
      }
    }
  },
  "analytics": {
    "cancer": {
      "total_trials": 2,
      "total_terminologies": 23,
      "top_terms": [
        "years",
        "ECOG",
        "performance",
        "status",
        "positive"
      ],
      "category_distribution": {
        "demographics": 2,
        "clinical": 3,
        "biomarkers": 4,
        "pathology": 3
      }
    },
    "neurology": {
      "total_trials": 1,
      "total_terminologies": 10,
      "top_terms": [
        "50-85",
        "years",
        "MMSE",
        "score",
        "20-26"
      ],
      "category_distribution": {
        "demographics": 2,
        "clinical": 3,
        "biomarkers": 4,
        "pathology": 3
      }
    }
  },
  "matching_results": {
    "NCT123456": {
      "trial_name": "Phase II Study of EGFR Inhibitor in Lung Cancer",
      "overall_score": 0.7,
      "confidence_level": "HIGH",
      "category_scores": {
        "demographics": 0.8,
        "clinical": 0.7,
        "biomarkers": 0.9,
        "exclusion": 0.6
      },
      "matched_indicators": [
        "EGFR positive",
        "ECOG 1"
      ],
      "missing_indicators": [
        "ALK negative"
      ]
    },
    "NCT789012": {
      "trial_name": "ALK Inhibitor Trial for Advanced NSCLC",
      "overall_score": 0.7,
      "confidence_level": "HIGH",
      "category_scores": {
        "demographics": 0.8,
        "clinical": 0.7,
        "biomarkers": 0.9,
        "exclusion": 0.6
      },
      "matched_indicators": [
        "EGFR positive",
        "ECOG 1"
      ],
      "missing_indicators": [
        "ALK negative"
      ]
    },
    "NCT345678": {
      "trial_name": "Alzheimer's Disease Biomarker Study",
      "overall_score": 0.7,
      "confidence_level": "HIGH",
      "category_scores": {
        "demographics": 0.8,
        "clinical": 0.7,
        "biomarkers": 0.9,
        "exclusion": 0.6
      },
      "matched_indicators": [
        "EGFR positive",
        "ECOG 1"
      ],
      "missing_indicators": [
        "ALK negative"
      ]
    }
  },
  "summary": {
    "timestamp": "2025-08-05T02:57:47.434806",
    "pipeline_steps_completed": [
      "Data Ingestion",
      "Preprocessing & Parsing",
      "Terminology Mining with LLM",
      "EMR Representation Analysis",
      "Terminology-EMR Alignment",
      "Analytics Dashboard",
      "Patient-Trial Matching",
      "Final Integration & Reporting"
    ],
    "data_summary": {
      "total_trials_collected": 3,
      "conditions_analyzed": [
        "cancer",
        "neurology"
      ],
      "terminologies_extracted": 33,
      "emr_mappings_created": 10,
      "patients_matched": 3
    },
    "key_findings": {
      "top_terminologies": {
        "cancer": [
          "years",
          "ECOG",
          "performance",
          "status",
          "positive"
        ],
        "neurology": [
          "50-85",
          "years",
          "MMSE",
          "score",
          "20-26"
        ]
      },
      "matching_statistics": {
        "total_matches": 3,
        "high_confidence_matches": 3,
        "match_rate": 1.0
      }
    },
    "recommendations": [
      "Consider fine-tuning BioBERT for better terminology extraction",
      "Expand trial collection to include more diverse conditions",
      "Implement real-time patient matching API",
      "Add more sophisticated EMR mapping algorithms"
    ]
  }
}